In addition, our data substantiate the hypothesis that NAFLD-induced liver damage is associated with an abnormal SIRT-PGC-1 signaling; however, all these changes were notably reversed by LMF-HSFx treatment. This evidence concerns the gene PPARGC1A and metabolic dysfunction-associated steatotic liver disease.